KRT19 and Patent ductus arteriosus: The growth rates of the tumors formed by these icOVA-expressing KRT19+ PDA cells were slower than those of tumors comprised of the non–icOVA-expressing KRT19+ PDA cells and similar to those of s/c tumors formed by Krt19-edited PDA cells not expressing icOVA (Fig. 4E).